Abiopharma

🔍 Wang Yanjun (Executive)

Company: Sea Ltd (SE)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Sold 600 shares of Class A ordinary shares at $112.67 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 18,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 89 shares of Class A ordinary shares at $114.1 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 17,911.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 685 shares of Class A ordinary shares at $114.89 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 17,226.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 90 shares of Class A ordinary shares at $115.86 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 17,136.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 18 shares of Class A ordinary shares at $116.9 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 17,118.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 18 shares of Class A ordinary shares at $117.58 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: false | shares_owned_after: 17,100.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 500 shares of Class A ordinary shares at $111.53 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 16,600.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 380 shares of Class A ordinary shares at $112.87 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 16,220.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 416 shares of Class A ordinary shares at $113.51 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 15,804.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 204 shares of Class A ordinary shares at $114.39 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: false | shares_owned_after: 15,600.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Holds 0 shares of Class A ordinary shares (Direct)
  Date: 2026-08-31 | Code: H | shares_owned_after: 1,132,842.00

Footnotes:

• F1: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by a BVI entity controlled by the Reporting Person on March 26, 2026.
• F2: Represents the weighted average price of shares sold at prices that ranged from $112.35 to $113.17. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
• F3: Represents the weighted average price of shares sold at prices that ranged from $113.47 to $114.33.
• F4: Represents the weighted average price of shares sold at prices that ranged from $114.40 to $115.32.
• F5: Represents the weighted average price of shares sold at prices that ranged from $115.39 to $116.28.
• F6: Represents the weighted average price of shares sold at prices that ranged from $116.78 to $116.96.
• F7: Represents the weighted average price of shares sold at prices that ranged from $117.49 to $117.77.
• F8: Represents the weighted average price of shares sold at prices that ranged from $111.10 to $112.01.
• F9: Represents the weighted average price of shares sold at prices that ranged from $112.15 to $113.09.
• F10: Represents the weighted average price of shares sold at prices that ranged from $113.12 to $114.09.
• F11: Represents the weighted average price of shares sold at prices that ranged from $114.10 to $114.73.